Therapeutic Systems was founded in 2008 by Brian Mullen after winning the UMass Amherst Innovation Challenge ($50k) and a VentureWell E-team grant to translate my PhD research from the research setting to the people in need. The company went on to raise seed funding, a gold winner of MassChallenge ($50k) and launch a FDA class I exempt product named Vayu (see below). Despite initial sales, promising pilot data and use cases the company closed in 2016. The lack of a mental health technology investment market at the time and a more difficult than expected FDA pathway drastically reduce the viability of the company.
Vision:
People with mental illness deserve the same quality and standard of care as people with physical illnesses.
Mission:
To improve the quality of care for people with mental illness and cognitive disabilities by providing evidence based and insurance reimbursed technologies to market.
Select Achievements:
UMass Amherst Innovation Challenge Winner ($50k)
MassChallenge prize winner ($50k)
Raised over $250k in seed funding
Launched product & generated revenue from sales.
Positively impact the lives and families of people with autism and mental illnesses.